Wordt geladen...

Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model

Metronomic cyclophosphamide (CPA) treatment activates robust innate anti-tumor immunity and induces major regression of large, implanted brain tumor xenografts when administered on an intermittent, every 6-day schedule, but not on a daily low-dose or a maximum-tolerated dose CPA schedule. Here, we u...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Wu, Junjie, Waxman, David J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2014
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4162810/
https://ncbi.nlm.nih.gov/pubmed/25069038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2014.07.033
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!